Frontiers in Microbiology · 2023 · 27 citations · 29 references
Life SciencesGeneticsOncologyCancer GeneticsCarcinogenesisMicrobiome ResearchBiliary Tract CancerGut MicrobiomeGut MicrobiotaMendelian RandomizationMolecular Risk FactorsBidirectional Mendelian RandomizationCancer BioinformaticsGut Microbiome AlterationsGut Microbiota CompositionGut Microbiota EffectsMicrobiome-associated CarcinogenesisSingle-nucleotide PolymorphismsTwo-sample Mendelian Randomization
Background Intrahepatic cholangiocarcinoma (ICC) is an aggressive liver cancer with poor prognosis. The gut microbiota has been linked to ICC, but evidence for causality is lacking. Elucidating causal gut microbiota-ICC links could inform prevention and treatment strategies. Materials and methods We performed a bidirectional two-sample Mendelian randomization (MR) study to investigate causal associations between gut microbiota and ICC risk. Genome-wide significant single nucleotide polymorphisms (SNPs) associated with gut microbiota abundances were utilized as instrumental variables (IVs). Multiple methods assessed causality and sensitivity analyses evaluated result robustness. Bioinformatics analysis of genetic loci linked to gut microbiota and ICC examined potential mechanisms. Results Genetically predicted increases in Veillonellaceae , Alistipes , Enterobacteriales , and Firmicutes were suggestively associated with higher ICC risk, while increases in Anaerostipes , Paraprevotella , Parasutterella , and Verrucomicrobia appeared protective. Bioinformatics analysis revealed differentially expressed genes near gut microbiota-associated loci may influence ICC through regulating pathways and tumor immune microenvironment. Conclusion Our findings provide suggestive evidence for causal links between specific gut microbiota and ICC risk.
29
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa et al. · Science · 2017 · 5.4K citations
Life Sciences, Immunology, Oncology +17
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, Luigi Nezi, Alexandre Reuben et al. · Science · 2017 · 4.7K citations · Full text
Life Sciences, Immunology, Oncology +17